Browse All

Current Filters

CLEAR FILTER x

TITLE

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial

Author:Fox, Robert   Bar-Or, Amit   Vermersch, Patrick   Oreja Guevara, Celia   Traboulsee, Anthony   Giovannoni, Gavin   Syed, Sana   Sun, Furong   Salloum, Naji   Turner, Timothy   Wallstroem, Erik   Reich, Daniel   

Session Name:PL6: Contemporary Clinical Issues Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL6.003  

Author Institution:Cleveland Clinic, Cleveland, OH  University of Pennsylvania, Philadelphia, PA  University of Lille, Lille, France  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  University of British Columbia, Vancouver, BC, Canada  Queen Mary University London, London, United Kingdom  Sanofi , Cambridge, MA  Sanofi, Morristown, NJ  Sanofi, CHILLY-MAZARIN, France  Sanofi, Cambridge, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  

Subgroup Analysis of the Phase Three Tolebrutinib HERCULES Trial: Disability Accumulation Outcomes in North American Participants

Author:Coyle, Patricia   Bar-Or, Amit   Reich, Daniel   Traboulsee, Anthony   Syed, Sana   Li, Ye   Vargas, Wendy   Fox, Robert   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.003  

Author Institution:Stony Brook University Renaissance School of Medicine, Stony Brook, NY  University of Pennsylvania, Philadelphia, PA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  University of British Columbia, Vancouver, BC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  Cleveland Clinic, Cleveland, OH